Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Preliminary of Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children (Phase I)

NCT04188223 is registered in ClinicalTrials.gov with PT Bio Farma as lead sponsor.

NCT NCT04188223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04188223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Preliminary of Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children (Phase I)
Lead sponsor
PT Bio Farma
Phase
Phase 1
Overall status
Completed
Start date
December 3, 2019
Completion date
July 16, 2020
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b